Premenstrual Dysphoric Disorder: Burden of Illness and Treatment Update
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Five percent of menstruating women have severe premenstrual symptoms and impairment of functioning defined as premenstrual dysphoric disorder (PMDD). Clinically significant premenstrual symptoms occur in at least an additional 20% of menstruating women. The diagnosis of PMDD should be confirmed by prospective symptom charting over 2 menstrual cycles to confirm the timing of the symptoms and to rule out other diagnoses. The burden of illness of PMDD includes disruption of parenting and partner relationships and decreased productivity in work roles. In addition, women with PMDD have increased use of health care services such as clinician visits and increased use of prescription medications and over-the-counter preparations. The etiology of PMDD is multifactorial. In particular, dysregulation of the serotonin and allopregnanolone systems is implicated. Several effective treatment options exist, including serotonergic antidepressant medications and an oral contraceptive that contains ethinyl estradiol and drosperinone. In addition, other hormones that suppress ovulation, anxiolytics, cognitive therapy, chasteberry and calcium may be helpful.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schmidt, P. J., Nieman, L. K., Danaceau, M. A., Adams, L. F., & Rubinow, D. R. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801223380401 · Cited by 765
The premenstrual symptoms screening tool (PSST) for clinicians
Steiner, M., Macdougall, M., & Brown, E. (2003) · Archives of Women's Mental Health · doi:10.1007/s00737-003-0018-4 · Cited by 641 · cited 2×
“Larger studies of women diagnosed retrospectively according to PMDD criteria have also reported substantial functional impairment in work and interpersonal roles.(11,12,37,38)”
Self-citationPrevalence, incidence and stability of premenstrual dysphoric disorder in the community
WITTCHEN, H.-U., BECKER, E., LIEB, R., & KRAUSE, P. (2002) · Psychological Medicine · doi:10.1017/s0033291701004925 · Cited by 554
Exercise and the Treatment of Clinical Depression in Adults: Recent Findings and Future Directions
Brosse, A. L., Sheets, E. S., Lett, H. S., & Blumenthal, J. A. (2002) · Sports Medicine · doi:10.2165/00007256-200232120-00001 · Cited by 505
Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: A systematic review
Dimmock, P. W., Wyatt, K. M., Jones, P. W., & O'Brien, P. S. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02754-9 · Cited by 368 · cited 5×
“Alprazolam 0.25 mg daily or twice daily (administered during the luteal phase only) has been reported to be more effective than placebo in most studies135–138 but not all.139 It is primarily effective for premenstrual tension and irritability, and overall, it has a lower efficacy rate than the SSRIs.”
InfluentialCognitive therapy for premenstrual syndrome
Blake, F., Salkovskis, P., Gath, D., Day, A., & Garrod, A. (1998) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(98)00042-7 · Cited by 196
Efficacy of progesterone and progestogens in management of premenstrual syndrome: systematic review
Wyatt, K., Dimmock, P., Jones, P., Obhrai, M., & O'Brien, S. (2001) · BMJ · doi:10.1136/bmj.323.7316.776 · Cited by 168 · cited 1×
“A previous systematic review of published RCTs of luteal-phase progesterone and progestogens reported that there was no clinically meaningful difference between all progesterone forms and placebo, although progesterone had a small statistically significant superiority over placebo.(97) A slight advantage for oral micr…”
Hunter, M. S., Ussher, J. M., Browne, S. J., Cariss, M., Jelley, R., & Katz, M. (2002) · Journal of Psychosomatic Obstetrics & Gynecology · doi:10.3109/01674820209074672 · Cited by 128 · cited 1×
“Another RCT examined the relative efficacy of fluoxetine 20 mg daily, 10 individual CT sessions or their combination in women with PMDD.(153,154) Efficacy rates at 6 months were comparable between the 3 treatments; however, at 1 year women who had received CT were coping better than those who had received fluoxetine a…”
A controlled study of light therapy in women with late luteal phase dysphoric disorder
Lam, R. W., Carter, D., Misri, S., Kuan, A. J., Yatham, L. N., & Zis, A. P. (1999) · Psychiatry Research · doi:10.1016/s0165-1781(99)00043-8 · Cited by 85
Hunter, M. S., Ussher, J. M., Cariss, M., Browne, S., Jelley, R., & Katz, M. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(02)00338-0 · Cited by 70 · cited 1×
“Another RCT examined the relative efficacy of fluoxetine 20 mg daily, 10 individual CT sessions or their combination in women with PMDD.(153,154) Efficacy rates at 6 months were comparable between the 3 treatments; however, at 1 year women who had received CT were coping better than those who had received fluoxetine a…”
The efficacy of cognitive behaviour therapy in treating premenstrual dysphoric changes
Christensen, A. P., & Oei, T. P. S. (1995) · Journal of Affective Disorders · doi:10.1016/0165-0327(94)00073-i · Cited by 62 · cited 1×
“Two studies in women with prospectively confirmed PMS reported superiority of individual CT for reducing premenstrual symptoms when compared with a waitlist control condition(151) and when compared with information-focused therapy.(152) Another RCT examined the relative efficacy of fluoxetine 20 mg daily, 10 individua…”
Perception of family and work environments in women with premenstrual syndrome
Kuczmierczyk, A. R., Labrum, A. H., & Johnson, C. C. (1992) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(92)90137-q · Cited by 55
Mitwally, M. F. M., Gotlieb, L., & Casper, R. F. (2002) · Menopause · doi:10.1097/00042192-200207000-00004 · Cited by 53
The effect of bright light therapy on depression associated with premenstrual dysphoric disorder
Krasnik, C., Montori, V. M., Guyatt, G. H., Heels-Ansdell, D., & Busse, J. W. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2005.01.055 · Cited by 47 · cited 1×
“Although a crossover study reported that evening bright light for 2 premenstrual weeks decreased depression and tension,(189) a meta-analysis of the few existing trials suggested a small effect size for bright light therapy.(190)”
Cited by
Dias, R. S., Lafer, B., Russo, C., Del Debbio, A., Nierenberg, A. A., Sachs, G. S., & Joffe, H. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09121816 · Cited by 70
Comorbid bipolar disorder and premenstrual dysphoric disorder: real patients, unanswered questions
Frey, B. N., & Minuzzi, L. (2013) · Archives of Women's Mental Health · doi:10.1007/s00737-012-0313-z · Cited by 22
Nillni, Y. I., Rohan, K. J., Mahon, J. N., Pineles, S. L., & Zvolensky, M. J. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2013.07.016 · Cited by 15
“There is a very small literature investigating psychological treatments for PMS symptoms (e.g., cognitive therapy, relaxation, diet and exercise changes; Pearlstein and Steiner, 2008).”
Background
Metadata
- Authors
- Pearlstein, T., & Steiner, M.
- Venue
- Focus
- Published
- 2012-01
- Volume
- 10
- Issue
- 1
- Pages
- 90-101
- ISSN
- 1541-4094 (ISSN-L)
- 1541-4108
- OpenAlex
- W1726678086
- Cited by
- 186
- References
- 14
- FWCI
- 15.63
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.